HIV-associated neurocognitive disorder in a KwaZulu-Natal HIV clinic: A prospective study
Open Access
- 31 January 2017
- journal article
- Published by AOSIS in Southern African Journal of HIV Medicine
- Vol. 18 (1), 5 pages
- https://doi.org/10.4102/sajhivmed.v18i1.732
Abstract
Introduction: HIV-associated neurocognitive disorder (HAND) is a consequence of HIV infection of the central nervous system. The prevalence ranges between 15% and 60% in different settings.Objectives: This prospective study determined the prevalence of HAND at a peri-urban HIV clinic in KwaZulu-Natal. Factors associated with HAND were examined, alternate neurocognitive tools were tested against the international HIV dementia scale (IHDS) score and an association between HAND and non-adherence to antiretroviral therapy (ART) was explored. Methods: Between May 2014 and May 2015, 146 ART-naïve outpatients were assessed for HAND. IHDS score ≤ 10 established a diagnosis of HAND. Functional capacity was assessed using Eastern Cooperative Oncology Group (ECOG) score. Chi-squared test was used to identify risk factors for HAND. The get-up-and-go test (GUGT) and Center for Epidemiological Studies Depression scale – revised (CESD-r) were tested against the IHDS. HIV viral load done six months after initiating ART was used as a surrogate marker for adherence to ART. Results: The prevalence of HAND was 53%. In total, 99.9% of patients with HAND had no functional impairment. Age > 50 years old was associated with HAND (p = 0.003). There was no correlation between the GUGT, CESD-r and the IHDS score. HAND was not associated with non-adherence (p = 0.06). Conclusions: While the prevalence of HAND is high, it is not associated with functional impairment which suggests that asymptomatic neurocognitive impairment is prevalent. Age > 50 years old is a risk factor for HAND. The GUGT and CESD-r are not useful diagnostic tools for HAND. The relationship between HAND and non-adherence should be further explored.Keywords
This publication has 36 references indexed in Scilit:
- A Systematic Review of the Screening Accuracy of the HIV Dementia Scale and International HIV Dementia ScalePLOS ONE, 2013
- Current understanding of HIV-associated neurocognitive disorders pathogenesisCurrent Opinion in Neurology, 2011
- Longitudinal Change in Cognitive Function and Medication Adherence in HIV-Infected AdultsAIDS and Behavior, 2011
- Validity of the International HIV Dementia Scale in South AfricaAIDS Patient Care and STDs, 2011
- HIV-associated neurocognitive disorders persist in the era of potent antiretroviral therapyNeurology, 2010
- Cognitive dysfunction in HIV patients despite long-standing suppression of viremiaAIDS, 2010
- Properties of the ‘Timed Up and Go’ Test: More than Meets the EyeGerontology, 2010
- Aging, Neurocognition, and Medication Adherence in HIV InfectionAmerican Journal of Geriatric Psychiatry, 2009
- Clinical Correlates of HIV-Associated Neurocognitive Disorders in South AfricaAIDS and Behavior, 2009
- Neurocognitive screening tools in HIV/AIDS: comparative performance among patients exposed to antiretroviral therapyHIV Medicine, 2009